Clinical trial
A Double-blinded, Prospective, Randomized, Controlled Trial Comparing Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders
NCT02266433 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blinded, Prospective, Randomized, Controlled Trial Comparing Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 31, 2012
- Completion date
- July 1, 2018
- Enrollment
- 245 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dequervains tenosynovitis, inflammatory disease, lateral epicondylitis, tennis elbow, tenosynovitis, trigger finger